How We Calculate the Aggregate

Source Classification System

Every financial figure in our database is tagged with one of three source confidence classifications. This system was developed to distinguish primary evidence from secondary reporting and estimation — a distinction that no other public tracker makes.

Aggregate Remaining Assets: How the Number Is Calculated

The aggregate "Estimated Remaining Assets" figure displayed on the homepage is a point-in-time sum of the net asset figures for all active trusts in our database, subject to the following methodology rules:

1. For each trust, we use the most recently available net asset figure, regardless of its as-of date.
2. Figures classified (a) are used as reported. Figures classified (b) are used as reported with a ±5% uncertainty band. Figures classified (c) are excluded from the point estimate and contribute only to the reported range.
3. The displayed figure is the documented floor: the exact sum of the latest located asset figure for each included trust. The broader range shown below the clock is a separately labeled estimate, not a midpoint calculation.
4. The aggregate is not inflation-adjusted and does not account for future claim liabilities or actuarial projections.
5. Trusts with no available net asset figure are excluded from the aggregate but are listed in the database with their known payment percentage data.

Historical Benchmarks and the "$30 Billion" Claim

No primary source reviewed by this project states that $30 billion is currently available in asbestos trusts. The phrase blends historical figures that measure different things and carry different as-of dates. The Government Accountability Office (GAO-11-819) reported in 2011 that 60 trusts had been established with approximately $37 billion in total assets and that available payment data showed about $17.5 billion paid through 2010. Those are historical system-wide observations, not a 2026 balance.

The closest documented origin is a 2013 House Judiciary witness statement that cites the 2012 Bates White / Mealey's overview. It described more than $18 billion in confirmed trust assets plus $11–12 billion in proposed trust assets pending confirmation. Combining those measures produces roughly $30 billion, but it is a 2012–2013 snapshot that included projected funding for unconfirmed reorganizations—not money currently available to claimants.

A later Bates White / Mealey's commentary reported roughly $18.6 billion in confirmed trust assets at year-end 2013, plus $160 million in deferred funding, while noting that several 2014 confirmations were expected to add funding. The U.S. Chamber Institute for Legal Reform's 2018 report, an advocacy publication, described nearly $25 billion in assets and more than $2 billion in deferred funding at year-end 2016. These are useful dated benchmarks, but neither is a current balance nor a substitute for a trust-by-trust filed-source review.

The tracker therefore does not treat "$30 billion available" as a sourceable fact. It is best understood as a stale marketing shorthand that has lost the underlying measure and date. It also must not be confused with this site's separate bottom-up estimate of cumulative payouts since 1988: $30,033,989,206 measures payments made or liquidated under the source series, not assets remaining.

Our documented floor for remaining assets is $16,033,489,279. It is a current-project calculation from the individually cited figures displayed in this database. It covers 43 of the tracker's 54 active records, not the approximately 60 trusts historically established nationwide. It is a floor, not a ceiling: no-balance records and unavailable or sealed filings are excluded, and the underlying reports have mixed as-of dates.

Per-Claimant Statistics: A Measured Void

Two questions dominate claimant-side search traffic — how many trusts does a typical claimant file with, and how much does a claimant recover in total — and no public dataset can answer either. Trusts see only their own claimants; no federal body collects cross-trust per-claimant filings. RAND states the limitation directly: "It is not possible to use trust-level data to determine the number of trusts providing payments to the same individual or the amount the trusts together pay to an individual claimant." (RAND TR-872, 2010, p. xvii)

The only measured figures in existence come from adversarial proceedings, and each measures something slightly different:

• 22 trusts alleged; about $600,000 in trust recoveries — the Garlock estimation ruling's "typical claimant," based on 2010-era data presented by the debtor's own expert and adopted in a contested proceeding (In re Garlock Sealing Technologies, 504 B.R. 71, 96 (Bankr. W.D.N.C. 2014), Findings of Fact ¶¶101–102). Payment percentages at many trusts have since been reduced, so these figures likely overstate today's recoveries.
• 18 trust claim forms actually filed — a study of 1,844 Crane Co. mesothelioma cases (2007–2011) matched to Garlock discovery data (Ableman, Kelso & Scarcella, 30:19 Mealey's Litig. Rep.: Asbestos 1, Nov. 4, 2015; verified against the authors' reprint). The closest measurement to "claims filed," from a two-defendant subset.
• ~13 trusts qualified for — a 2024 study of Philadelphia mesothelioma dockets (U.S. Chamber ILR, March 2024). A different quantity (eligibility, not filings), no dollar figure, and defense-side sponsorship.

Every measured figure is defense- or debtor-side in origin; no neutral or plaintiffs'-side measurement exists. The marketing figures that circulate instead — a "$41,000 average payout" (a RAND per-claim median at one trust, misdescribed) and "$300,000–$400,000 total recoveries" (no identifiable source) — should not be cited. There is also no referee: the U.S. Trustee Program's director testified in 2017 that for post-confirmation asbestos trusts "there is no independent policeman. There is no watchdog for that." (CHRG-115hhrg27890) GAO-11-819 found that where trusts did audit claims, "none indicated that these audits had identified cases of fraud."

Known Data Gaps

The following gaps exist in our current dataset. We document them explicitly rather than papering over them with estimates.

Oversight and Audit Context

GAO's 2011 review found that the 44 trust agreements it examined required annual financial reports to the bankruptcy court, while each trust retained discretion over what additional claim and payment information it released publicly. That is why this tracker distinguishes a filed report, a trust-posted notice, a secondary compilation, and a gap rather than treating each as interchangeable.

GAO's discussion of audit practices is deliberately limited: officials at 2 of the 11 trusts interviewed described random or targeted claim samples, and one described an external audit that sent a sample of X-rays to an independent doctor. Officials who discussed audits did not report that those audits had identified fraud. Those findings describe a small interview sample; they are not a system-wide fraud rate or a basis to infer that every trust uses the same process.

In a 2017 House Judiciary hearing record, then-U.S. Trustee Program Director Clifford J. White III said that, for post-confirmation asbestos trusts, “there is no independent policeman. There is no watchdog.” We present that as his oversight observation in its hearing context—not as a quantified finding about any particular trust or claim.

Cumulative Payouts Methodology

The cumulative payouts clock displays $30,033,989,206 — a bottom-up estimate of total claims paid or liquidated by all U.S. asbestos bankruptcy trusts since 1988 under the source series’ disclosed conventions. This figure replaced a round $24 billion placeholder in July 2026. The methodology is documented in full at docs/methodology-cumulative-payouts.md in the project repository.

Why the Number Changed from $24B to ~$30B

The $24B was a top-down placeholder anchored on 2011 GAO data. Three independent anchors all pointed higher:

• GAO-11-819's "$17.5 billion paid" was frozen at December 31, 2010 — it says nothing about the last 15+ years of payments.
• Bates White / Mealey's tables document $14.0 billion paid in 2006–2011 alone — six years.
• The research corpus's own assessment: cumulative payments by 2026 are "plausibly $30B+" (RAND documented ~$3.3B of trust outlays in 2008 alone).

Three-Tier Build

Honest Caveats

1. Floor-leaning estimate. Several Tier 1/2 as-of dates are stale; payments after those dates are only partly captured. Babcock & Wilcox is a stated floor.
2. The residual is an allowance, not a measurement. We publish the range ($2.5–5B), not false precision.
3. Tier 2 figures graduate to Tier 1 as PACER pulls land — see the queue in the project repository.
4. No class-c marketing-site figures. Nothing from mesothelioma.com, asbestosclaims.law, or similar sites is used anywhere in this build.

Recent Revision Log

Update Schedule

The database is updated on the following schedule: